Reply to ‘Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials’: reply from the authors

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Biologic Therapies ◽

How current biologic therapies affect the risk of major adverse cardiovascular events in patients with plaque psoriasis? A systematic review and meta-analysis of randomized controlled trials

Advances in Dermatology and Allergology ◽

10.5114/ada.2020.102121 ◽

2020 ◽

Vol 37 (6) ◽

pp. 986-994

Author(s):

Sonia Nartowicz ◽

Ewelina Jakielska ◽

Monika Priadka ◽

Zygmunt Adamski ◽

Piotr Ratajczak ◽

...

Keyword(s):

Systematic Review ◽

Plaque Psoriasis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Biologic Therapies ◽

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials

British Journal of Dermatology ◽

10.1111/bjd.14964 ◽

2017 ◽

Vol 176 (4) ◽

pp. 890-901 ◽

Cited By ~ 51

Author(s):

W. Rungapiromnan ◽

Z.Z.N. Yiu ◽

R.B. Warren ◽

C.E.M. Griffiths ◽

D.M. Ashcroft

Keyword(s):

Systematic Review ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Biologic Therapies ◽

A reply to: ‘Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials'

British Journal of Dermatology ◽

10.1111/bjd.15620 ◽

2017 ◽

Vol 177 (2) ◽

pp. 580-581 ◽

Cited By ~ 1

Author(s):

M. Amin ◽

D.J. No ◽

J.J. Wu

Keyword(s):

Systematic Review ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Biologic Therapies ◽

Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trials

BMC Cardiovascular Disorders ◽

10.1186/s12872-020-01466-5 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Yara Wanas ◽

Rim Bashir ◽

Nazmul Islam ◽

Luis Furuya-Kanamori

Keyword(s):

Systematic Review ◽

Cardiovascular Events ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Major Cardiovascular Events ◽

Receptor Blockers

The effects of renin–angiotensin system inhibitors on mortality, cardiovascular events, and renal events in hypertensive patients with diabetes: a systematic review and meta-analysis of randomized controlled trials

Hypertension Research ◽

10.1038/s41440-019-0234-6 ◽

2019 ◽

Vol 42 (5) ◽

pp. 669-680 ◽

Cited By ~ 3

Author(s):

Ayako Kunimura ◽

Nobuaki Himuro ◽

Akira Fujiyoshi ◽

Hiroyoshi Segawa ◽

Hirofumi Ohnishi ◽

...

Keyword(s):

Systematic Review ◽

Cardiovascular Events ◽

Meta Analysis ◽

Renin Angiotensin System ◽

Controlled Trials ◽

Angiotensin System ◽

Hypertensive Patients ◽

Randomized Controlled ◽

Patients With Diabetes

Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Journal of the American Heart Association ◽

10.1161/jaha.115.002849 ◽

2016 ◽

Vol 5 (2) ◽

Cited By ~ 26

Author(s):

Lee H. Sterling ◽

Sarah B. Windle ◽

Kristian B. Filion ◽

Lahoud Touma ◽

Mark J. Eisenberg

Keyword(s):

Systematic Review ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Effects of exenatide long-acting release on cardiovascular events and mortality in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Acta Diabetologica ◽

10.1007/s00592-019-01347-0 ◽

2019 ◽

Vol 56 (9) ◽

pp. 1051-1060

Author(s):

B. M. Bonora ◽

A. Avogaro ◽

G. P. Fadini

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Long Acting

Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2012.04500.x ◽

2012 ◽

Vol 27 (5) ◽

pp. 622-627 ◽

Cited By ~ 105

Author(s):

T. Tzellos ◽

A. Kyrgidis ◽

C. C. Zouboulis

Keyword(s):

Plaque Psoriasis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Biological Agents ◽

Controlled Trials ◽

Chronic Plaque Psoriasis ◽

FRI0127 IMPACT OF JANUS KINASE INHIBITORS ON RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

10.1136/annrheumdis-2019-eular.472 ◽

2019 ◽

Author(s):

Wenhui Xie ◽

Shiyu Xiao ◽

Yanrong Huang ◽

Xiaoying Sun ◽

Yong Fan ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Cardiovascular Events ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Janus Kinase ◽

Controlled Trials ◽

Janus Kinase Inhibitors ◽

Faculty Opinions recommendation of Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718444775.793533046 ◽

2017 ◽

Author(s):

Jeffrey Weitz

Keyword(s):

Myocardial Infarction ◽

Systematic Review ◽

Major Bleeding ◽

Cardiovascular Events ◽

Meta Analysis ◽

Dabigatran Etexilate ◽

Controlled Trials ◽

Randomized Controlled ◽

All Cause Mortality